Robert E. Hoffman insider trades

Open-market stock purchases and sales by Robert E. Hoffman, Director at FibroBiologics, Inc, from SEC Form 4 filings since Feb 15, 2022.

Recent trades

DateStockTradeValue
Jun 23, 2026FBLG FibroBiologics, IncBought (not open market)—
May 28, 2026ESPR Esperion Therapeutics, IncBought (not open market)—
Mar 20, 2026CYDY CytoDyn IncBought (not open market)—
Feb 12, 2026HURA TuHURA Biosciences, Inc./NVBought (not open market)—

Companies traded

  • FBLG FibroBiologics, Inc: other filings, last Jun 23, 2026
  • ESPR Esperion Therapeutics, Inc: other filings, last May 28, 2026
  • CYDY CytoDyn Inc: other filings, last Mar 20, 2026
  • HURA TuHURA Biosciences, Inc./NV: other filings, last Feb 12, 2026
  • KTRA Kintara Therapeutics, Inc: 1 buy, last Aug 30, 2023

Get free alerts when Robert E. Hoffman files a new trade →